Actiq
Company: Anesta Corporation
Approval Status: Approved November 1998
Treatment for: Oncology
Areas: Oncology
| General Information | Side Effects | Mechanism of Action |
General Information
Actiq is used for the management of cancer pain in patients with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
Actiq is used to relieve the flares, called breakthrough cancer pain, that your regular prescribed pain medication does not control.
Actiq should not be used for:
- Short-term pain, e.g. pain from injuries or surgery
- Pain that is already being treated with a prescription opioid (narcotic) pain medicine every day on a regular schedule
Side Effects
Sleepiness, nausea or dizziness.
Mechanism of Action
Actiq contains a prescription opioid (narcotic) pain-relieving medicine called fentanyl. When you place it in your mouth it slowly dissolves, and the medicine is absorbed through the lining of your mouth. From there, it goes into your bloodstream.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
